United States · FDA National Drug Code directory
Maxi Nicotine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0363-0960_fc34920e-93d7-40e0-803c-ad0a5f8e4060
- Product NDC
- 0363-0960
- Form
- LOZENGE
- Composition / generic term
- nicotine polacrilex
- Labeler
- Walgreens
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201030 / 20270430
Source-listed ingredients
- NICOTINE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 BOTTLE, PLASTIC in 1 BOX (0363-0960-08) / 27 LOZENGE in 1 BOTTLE, PLASTIC · 0363-0960-08
- 1 BOTTLE, PLASTIC in 1 BOX (0363-0960-24) / 24 LOZENGE in 1 BOTTLE, PLASTIC · 0363-0960-24
- 1 BOTTLE, PLASTIC in 1 BOX (0363-0960-27) / 27 LOZENGE in 1 BOTTLE, PLASTIC · 0363-0960-27
- 3 BOTTLE, PLASTIC in 1 BOX (0363-0960-72) / 24 LOZENGE in 1 BOTTLE, PLASTIC · 0363-0960-72
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →